216 related articles for article (PubMed ID: 19188684)
1. Somatic mutation and functional polymorphism of a novel regulatory element in the HGF gene promoter causes its aberrant expression in human breast cancer.
Ma J; DeFrances MC; Zou C; Johnson C; Ferrell R; Zarnegar R
J Clin Invest; 2009 Mar; 119(3):478-91. PubMed ID: 19188684
[TBL] [Abstract][Full Text] [Related]
2. Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells.
Shackleford TJ; Zhang Q; Tian L; Vu TT; Korapati AL; Baumgartner AM; Le XF; Liao WS; Claret FX
Breast Cancer Res; 2011 Jun; 13(3):R65. PubMed ID: 21689417
[TBL] [Abstract][Full Text] [Related]
3. A novel transcriptional regulatory region within the core promoter of the hepatocyte growth factor gene is responsible for its inducibility by cytokines via the C/EBP family of transcription factors.
Jiang JG; Zarnegar R
Mol Cell Biol; 1997 Oct; 17(10):5758-70. PubMed ID: 9315634
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor (HGF), keratinocyte growth factor (KGF), and their receptors in human breast cells and tissues: alternative receptors.
Wilson SE; Weng J; Chwang EL; Gollahon L; Leitch AM; Shay JW
Cell Mol Biol Res; 1994; 40(4):337-50. PubMed ID: 7866434
[TBL] [Abstract][Full Text] [Related]
5. MMTV-associated transcription factor binding sites increase nm23-H1 metastasis suppressor gene expression in human breast carcinoma cell lines.
Ouatas T; Clare SE; Hartsough MT; De La Rosa A; Steeg PS
Clin Exp Metastasis; 2002; 19(1):35-42. PubMed ID: 11918081
[TBL] [Abstract][Full Text] [Related]
6. Genomic instability causes HGF gene activation in colon cancer cells, promoting their resistance to necroptosis.
Seneviratne D; Ma J; Tan X; Kwon YK; Muhammad E; Melhem M; DeFrances MC; Zarnegar R
Gastroenterology; 2015 Jan; 148(1):181-191.e17. PubMed ID: 25244939
[TBL] [Abstract][Full Text] [Related]
7. Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.
Anisowicz A; Sotiropoulou G; Sager R
Mol Med; 1999 Aug; 5(8):526-41. PubMed ID: 10501656
[TBL] [Abstract][Full Text] [Related]
8. Functional mononucleotide repeat polymorphism in the promoter region of HGF is associated with risk and malignant aggressiveness of bladder cancer.
Chiba S; Tsuchiya N; Horikawa Y; Narita S; Inoue T; Akihama S; Saito M; Numakura K; Tsuruta H; Huang M; Satoh S; Habuchi T
Int J Oncol; 2014 Mar; 44(3):678-84. PubMed ID: 24366484
[TBL] [Abstract][Full Text] [Related]
9. An upstream regulatory element confers orientation-independent enhancement of the TSG101 promoter activity in transformed cells.
Hsu SF; Goan YG; Tsai HY; Lin YR; Liu RT; Cheng JT
Mol Biol Rep; 2012 Jan; 39(1):517-25. PubMed ID: 21556761
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma-mediated transcriptional up-regulation of the hepatocyte growth factor gene promoter via a novel composite cis-acting element.
Jiang JG; Johnson C; Zarnegar R
J Biol Chem; 2001 Jul; 276(27):25049-56. PubMed ID: 11292834
[TBL] [Abstract][Full Text] [Related]
11. Co-operative effect of c-Src tyrosine kinase and Stat3 in activation of hepatocyte growth factor expression in mammary carcinoma cells.
Hung W; Elliott B
J Biol Chem; 2001 Apr; 276(15):12395-403. PubMed ID: 11278729
[TBL] [Abstract][Full Text] [Related]
12. Activating transcription factor-1-mediated hepatocyte growth factor-induced down-regulation of thrombospondin-1 expression leads to thyroid cancer cell invasion.
Ghoneim C; Soula-Rothhut M; Blanchevoye C; Martiny L; Antonicelli F; Rothhut B
J Biol Chem; 2007 May; 282(21):15490-7. PubMed ID: 17409099
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of the hepatocyte growth factor (HGF) gene by the Sp family of transcription factors.
Jiang JG; Chen Q; Bell A; Zarnegar R
Oncogene; 1997 Jun; 14(25):3039-49. PubMed ID: 9223667
[TBL] [Abstract][Full Text] [Related]
14. The repressive function of AP2 transcription factor on the hepatocyte growth factor gene promoter.
Jiang JG; DeFrances MC; Machen J; Johnson C; Zarnegar R
Biochem Biophys Res Commun; 2000 Jun; 272(3):882-6. PubMed ID: 10860846
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional characterization of the mouse hepatocyte growth factor gene promoter.
Liu Y; Michalopoulos GK; Zarnegar R
J Biol Chem; 1994 Feb; 269(6):4152-60. PubMed ID: 8307976
[TBL] [Abstract][Full Text] [Related]
16. The concerted regulatory functions of the transcription factors nuclear factor-1 and upstream stimulatory factor on a composite element in the promoter of the hepatocyte growth factor gene.
Jiang JG; Gao B; Zarnegar R
Oncogene; 2000 May; 19(23):2786-90. PubMed ID: 10851080
[TBL] [Abstract][Full Text] [Related]
17. The hepatocyte growth factor regulatory factors in human breast cancer.
Parr C; Watkins G; Mansel RE; Jiang WG
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):202-11. PubMed ID: 14734471
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1.
Seol DW; Chen Q; Zarnegar R
Oncogene; 2000 Feb; 19(9):1132-7. PubMed ID: 10713700
[TBL] [Abstract][Full Text] [Related]
19. The role of hepatocyte growth factor (scatter factor) in epithelial-mesenchymal transition and breast cancer.
Elliott BE; Hung WL; Boag AH; Tuck AB
Can J Physiol Pharmacol; 2002 Feb; 80(2):91-102. PubMed ID: 11934261
[TBL] [Abstract][Full Text] [Related]
20. Sp1 regulates expression of MET, and ribozyme-induced down-regulation of MET in fibrosarcoma-derived human cells reduces or eliminates their tumorigenicity.
Liang H; O'Reilly S; Liu Y; Abounader R; Laterra J; Maher VM; McCormick JJ
Int J Oncol; 2004 May; 24(5):1057-67. PubMed ID: 15067326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
